Your browser doesn't support javascript.
loading
COVID-19 Disease and Vitamin D: A Mini-Review.
Boulkrane, Mohamed Said; Ilina, Victoria; Melchakov, Roman; Fedotova, Julia; Drago, Filippo; Gozzo, Lucia; Das, Undurti Narasimha; Abd El-Aty, A M; Baranenko, Denis.
Afiliación
  • Boulkrane MS; International Research Centre "Biotechnologies of the Third Millennium", ITMO University, Saint-Petersburg, Russia.
  • Ilina V; International Research Centre "Biotechnologies of the Third Millennium", ITMO University, Saint-Petersburg, Russia.
  • Melchakov R; International Research Centre "Biotechnologies of the Third Millennium", ITMO University, Saint-Petersburg, Russia.
  • Fedotova J; Laboratory of Neuroendocrinology, I.P. Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia.
  • Drago F; Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Gozzo L; Department of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy.
  • Das UN; Department of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy.
  • Abd El-Aty AM; UND Life Sciences, Battle Ground, WA, United States.
  • Baranenko D; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Front Pharmacol ; 11: 604579, 2020.
Article en En | MEDLINE | ID: mdl-33390994
ABSTRACT
Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Rusia